ESCI期刊Current Reviews in Clinical and Experimental Pharmacology 2024/2025影響因子:1.329 (CURR REV CLIN EXP PH) (2772-4328).

只看該作者 · 發(fā)表于 2025-3-26 21:09:34

Submitted on: 06 February 2003. Revised on: 03 May 2003. Accepted on: 22 May 2003. ___________________Current Reviews in Clinical and Experimental Pharmacology

只看該作者 · 發(fā)表于 2025-3-27 04:30:11

Submitted on: 10 September 1998. Revised on: 28 December 1998. Accepted on: 07 February 1999. ___________________Current Reviews in Clinical and Experimental Pharmacology

只看該作者 · 發(fā)表于 2025-3-27 05:24:29

Submitted on: 31 May 2008. Revised on: 01 July 2008. Accepted on: 24 August 2008. ___________________Current Reviews in Clinical and Experimental Pharmacology

只看該作者 · 發(fā)表于 2025-3-27 13:22:50

只看該作者 · 發(fā)表于 2025-3-27 14:08:55

Submitted on: 14 May 2016. Revised on: 04 June 2016. Accepted on: 18 June 2016. ___________________Current Reviews in Clinical and Experimental Pharmacology

只看該作者 · 發(fā)表于 2025-3-27 18:31:31

		自動登錄	找回密碼
密碼			To register

關于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 05:32
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權所有 All rights reserved